Related references
Note: Only part of the references are listed.Usefulness of High-Sensitivity C-Reactive Protein to Predict Mortality in Patients With Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)
Jose Hermida et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Brain Natriuretic Peptide Levels as a Predictor for New Atrial Fibrillation During Hospitalization in Patients With Acute Ischemic Stroke
Kensaku Shibazaki et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Ziad Hijazi et al.
CIRCULATION (2012)
Role of inflammation in early atrial fibrillation recurrence
Marcelle D. Smit et al.
EUROPACE (2012)
Personalized medicine: hope or hype?
Keyan Salari et al.
EUROPEAN HEART JOURNAL (2012)
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H. Hohnloser et al.
EUROPEAN HEART JOURNAL (2012)
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
Amitava Banerjee et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Elevated plasma brain natriuretic peptide levels predict left atrial appendage dysfunction in patients with acute ischemic stroke
Harutoshi Tamura et al.
JOURNAL OF CARDIOLOGY (2012)
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
V. Roldan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Impact of Impaired Renal Function and Metabolic Syndrome on the Recurrence of Atrial Fibrillation after Catheter Ablation: A Long Term Follow-Up
Alexander Berkowitsch et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2012)
Associations Between Renal Function, Atrial Substrate Properties and Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
Tze-Fan Chao et al.
CIRCULATION JOURNAL (2011)
Predictive value of plasma Nt-proBNP and body mass index for recurrence of atrial fibrillation after cardioversion
Matthias K. Freynhofer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Renal Dysfunction and Atrial Fibrillation Recurrence Following Cardioversion
Martin Schmidt et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2011)
INTERLEUKIN-6 AND C-REACTIVE PROTEIN AND RISK FOR DEATH AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Julia K. Aulin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Use of Amino-Terminal Pro-B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis
Ruth Dubin et al.
BMC NEPHROLOGY (2011)
Relation of Recurrence of Atrial Fibrillation After Successful Cardioversion to Renal Function
Martin Schmidt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation
Yenn-Jiang Lin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
Evangelos Giannitsis et al.
CLINICAL CHEMISTRY (2010)
Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
Wanwarat Ananthapanyasut et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
C-Reactive Protein, Left Atrial Volume, and Atrial Fibrillation: A Prospective Study in High-Risk Elderly
Grace Casaclang-Verzosa et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Impaired Kidney Function and Atrial Fibrillation in Elderly Subjects
Rajat Deo et al.
JOURNAL OF CARDIAC FAILURE (2010)
Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy
Tsuneaki Sadanaga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk? A Mendelian Randomization of 47,000 Individuals From the General Population
Sarah C. W. Marott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation
J. Gustav Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
G. Michael Felker et al.
AMERICAN HEART JOURNAL (2009)
Relation of Kidney Function and Albuminuria With Atrial Fibrillation (from the Heart and Soul Study)
David D. McManus et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation
Renate B. Schnabel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation The Cardiovascular Health Study
Kristen K. Patton et al.
CIRCULATION (2009)
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Alan S. Go et al.
CIRCULATION (2009)
Normal Plasma Levels of Cardiac Troponin I Measured by the High-Sensitivity Cardiac Troponin I Access Prototype Assay and the Impact on the Diagnosis of Myocardial Ischemia
Per Venge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
Jonathan P. Piccini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Holger Reinecke et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
Renate B. Schnabel et al.
LANCET (2009)
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
Torbjorn Omland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Atrial Fibrillation and CHADS2 Risk Factors are Associated with Highly Sensitive C-Reactive Protein Incrementally and Independently
Mark A. Crandall et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2009)
Relation of Atrial Fibrillation to Glomerular Filtration Rate
Yasuyuki Iguchi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease
Jun Wang et al.
ATHEROSCLEROSIS (2008)
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects
Kai M. Eggers et al.
EUROPEAN HEART JOURNAL (2008)
Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation
Kazumasa Ohara et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative Therapeutics
Dobromir Dobrev et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion
Panagiotis Korantzopoulos et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2008)
Natriureettic peptides
Lori B. Daniels et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Role of inflammation in initiation and perpetuation of atrial fibrillation - A systematic review of the published data
Tim T. Issac et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study
Bahar Pirat et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
Seiji Habara et al.
EUROPEAN HEART JOURNAL (2007)
Relation of c-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion
Maria Luisa Loricchio et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
Gregg C. Fonarow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure -: The STARS-BNP multicenter study
Patrick Jourdain et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation - Relationship to stroke risk factors, stroke risk stratification schema, and prognosis
Gregory Y. H. Lip et al.
STROKE (2007)
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Joachim H. Ix et al.
CIRCULATION (2007)
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
Rhidian J. Shelton et al.
EUROPEAN HEART JOURNAL (2006)
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
Michael G. Shlipak et al.
ANNALS OF INTERNAL MEDICINE (2006)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -: executive summary -: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Valentin Fuster et al.
EUROPEAN HEART JOURNAL (2006)
Atrial secretion of B-type natriuretic peptide
Jens Peter Goetze et al.
EUROPEAN HEART JOURNAL (2006)
Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation
Takumi Yamada et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion
E Watanabe et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men - A community-based cohort study
B Zethelius et al.
CIRCULATION (2006)
Cystatin C and mortality risk in the elderly: The health, aging, and body composition study
Michael G. Shlipak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Is atrial fibrillation an inflammatory disorder?
CJ Boos et al.
EUROPEAN HEART JOURNAL (2006)
Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients
S Genovesi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
High sensitivity C-reactive protein - A novel predictor for recurrence of atrial fibrillation after successful cardioversion
JF Malouf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion
N Lellouche et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Cystatin C and the risk of death and cardiovascular events among elderly persons
MG Shlipak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded
A Jeremias et al.
ANNALS OF INTERNAL MEDICINE (2005)
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation
V Roldán et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation
SN Psychari et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
C Kragelund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation
PT Ellinor et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
C-reactive protein and microalbuminuria are associated with atrial fibrillation
FW Asselbergs et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
EL Knight et al.
KIDNEY INTERNATIONAL (2004)
Biochemical indicators of cardiac and renal function in a healthy elderly population
N Johnston et al.
CLINICAL BIOCHEMISTRY (2004)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Atrial fibrillation and heart failure: natural history and pharmacological treatment
I Savelieva et al.
EUROPACE (2004)
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
DSG Conway et al.
AMERICAN HEART JOURNAL (2004)
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation
DSG Conway et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation
J Dernellis et al.
EUROPEAN HEART JOURNAL (2004)
Frequency of elevation of C-reactive protein in atrial fibrillation
JL Anderson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation
B Wozakowska-Kaplon
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation
DSG Conway et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cystatin C - A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome
T Jernberg et al.
CIRCULATION (2004)
Relation of interleukin-6,C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation
DSG Conway et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation
V Marín et al.
HEART (2004)
Inflammation as a risk factor for atrial fibrillation
RJ Aviles et al.
CIRCULATION (2003)
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes:: findings from the global registry of acute coronary events (GRACE)
JJ Santopinto et al.
HEART (2003)
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
TB Horwich et al.
CIRCULATION (2003)
Elevated risk of stroke among patients with end-stage renal disease
SL Seliger et al.
KIDNEY INTERNATIONAL (2003)
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy
SK James et al.
CIRCULATION (2003)
D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation
M Somlói et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Thrombosis in end-stage renal disease
LF Casserly et al.
SEMINARS IN DIALYSIS (2003)
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome - A GUSTO-IV substudy
SK James et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
C-reactive protein and other inflammatory risk markers in acute coronary syndromes
GJ Blake et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Brain natriuretic peptide is elevated in outpatients with atrial fibrillation
H Silvet et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women
TSM Tsang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Plasma brain natriuretic peptide concentration: Impact of age and gender
MM Redfield et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes
J Al Suwaidi et al.
CIRCULATION (2002)
Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study
P Jourdain et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy
MK Higashi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation
H Shimizu et al.
STROKE (2002)
C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation
MK Chung et al.
CIRCULATION (2001)
Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state
Y Igarashi et al.
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2001)
Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
F Boomsma et al.
CARDIOVASCULAR RESEARCH (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
B Lindahl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation
S Inoue et al.
JOURNAL OF CARDIAC FAILURE (2000)
Share Paper
